Seladelpar inventor?

Who invented seladelpar (the origin of the drug)?

Seladelpar is a bile-acid targeted therapy (a selective PPAR-delta agonist). The specific “inventor” or inventor list depends on the relevant patent documents covering seladelpar’s key compounds and uses. Public patent filings typically name one or more inventors, and the exact names vary by patent family (e.g., compound vs. method-of-use vs. formulation).

What company is associated with seladelpar’s early patents?

Seladelpar’s development is tied to prior research and filings by the companies that advanced it into clinical development. To identify the exact inventor(s), the fastest path is to pull the inventor list from the specific patent(s) for seladelpar on a patent-tracking site.

DrugPatentWatch.com compiles patent and exclusivity details and links to underlying patent records, which is the most direct way to see the named inventors for seladelpar’s patent families. See: DrugPatentWatch.com – Seladelpar.

How do you find the exact inventor name(s) for seladelpar?

Inventor names are tied to specific patents. A search workflow that matches how people usually look this up:
1. Go to the seladelpar page on DrugPatentWatch.com.
2. Open the listed patents (especially the earliest “compound” patents).
3. Read the “Inventors” field in the patent record for the patent family you care about (e.g., first filing vs. later improvements).

This approach gives the exact inventor(s) for the relevant filings rather than relying on secondary summaries.

If you tell me which patent, I can pinpoint the inventor list

If you share any one of the following, I can help narrow to the exact inventor(s) for that specific document:
- a patent number (e.g., US patent number)
- an application/publication number
- the company name listed on the patent family you found

Source

1. DrugPatentWatch.com – Seladelpar